GARDASIL 9
9-valent HPV L1 protein (types 6, 11, 16, 18, 31, 33, 45, 52, 58)
0.5 mL · suspension · intramuscular · 9 to 45 years
HPV
GARDASIL 9 · CERVARIX
One, two or three doses depending on your age and health. Every product below is a Health Canada authorized vaccine; every schedule comes from the Canadian Immunization Guide.
Brand names and DINs (Drug Identification Numbers) as Health Canada's Drug Product Database lists them. The product monograph is the manufacturer's full prescribing information approved by Health Canada.
9-valent HPV L1 protein (types 6, 11, 16, 18, 31, 33, 45, 52, 58)
0.5 mL · suspension · intramuscular · 9 to 45 years
Bivalent HPV L1 protein (types 16, 18)
0.5 mL · suspension · intramuscular · females 9 to 45 years
Based on the Canadian Immunization Guide's administration practices and acute reactions guidance.
Can be offered in pregnancy; it is usually deferred until after, and a dose given before pregnancy was known is not a concern.
Use if indicated.
Source: Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026. Live vaccines are generally contraindicated in pregnancy; routinely recommended vaccines can be given while breastfeeding unless the chapter says otherwise.
The schedules the Canadian Immunization Guide describes for this vaccine. Which one applies depends on age, health and product — use the dose planner to see the dates for your situation.
One dose of 9-valent HPV vaccine for people who start at age 9 through 20.
Age at the first dose decides the schedule. A 2-dose schedule may be considered on an individual basis. People who are immunocompromised or living with HIV need three doses.
Optional two-dose schedule, at least 24 weeks apart.
May be considered individually for people who start at age 9 through 20, after discussion with a healthcare provider. The two doses must be at least 24 weeks apart.
Two doses of 9-valent HPV vaccine at least 24 weeks apart.
Recommended for people 21 through 26 years of age: two doses at least 24 weeks (6 months) apart.
Two doses at least 24 weeks apart, decided with a healthcare provider.
At 27 years and older, HPV vaccination is a shared decision with a healthcare provider (GARDASIL 9 is authorized to 45 years). When given: two doses at least 24 weeks apart.
Three doses of 9-valent HPV vaccine at months 0, 2 and 6.
For people 9 years and older who are immunocompromised or living with HIV, regardless of age. Minimum intervals: 4 weeks between doses 1 and 2, 12 weeks between doses 2 and 3, and 24 weeks between doses 1 and 3.
Three doses of bivalent HPV vaccine at months 0, 1 and 6.
CERVARIX (HPV2) is authorized for females 9 to 45 years of age. The 9-valent vaccine is the preferred product in Canada; use this schedule only when CERVARIX is the product actually given or the series was started on it.
Clinical rules reviewed on 2026-09-27. General information from public Canadian guidance; a personal assessment is needed for treatment decisions. Care365 does not decide whether a vaccine is publicly funded in Ontario.